Introduction
Lung cancer is a kind of cancer with the highest mortality rate around the world. According to clinical manifestations, lung cancer can be categorized into nonsmall cell lung cancer and small cell lung cancer. Greatly different from epithelial cancer (such as adenocarcinoma and squamous cell carcinoma) in biomorphology and development, small cell lung cancer is highly malignant, spreads rapidly in the early period after onset, and is very sensitive to chemotherapy and radiotherapy. Chemotherapy, radiotherapy, surgery and biotherapy are the major treatment modalities of small cell lung cancer. The key step of small cell lung cancer treatment is to know cell changes in cancer tissue. 5-Aza-2'-deoxycitydine (DAC), a DNA methyltransferase inhibitor, has been used to deteriorate hypermethylated gene expression, inhibit the growth of various cells [1] [2] [3] , accelerate tumor necrosis factormediated malignant melanoma cell apoptosis and promote the expression of quiescent gene MAGE-1 [4] [5] [6] . In addition, DAC can inhibit DNA and protein synthesis in tumor cells by inhibiting intracellular dihydrofolate reductase expression [7, 8] . This can stop the growth of cancer cells and even lead to cellular death. This study investigated the effects of DAC on the proliferation, apoptosis and lipid peroxidation of human lung adenocarcinoma epithelial cell line A549 and the underlying mechanisms in order to provide theoretical evidence for clinical use of DAC.
Materials and methods

Materials
Cells and their culture
Human lung adenocarcinoma epithelial cell line A549 (China Center for Type Culture Collection, Zhejiang University, China) was cultured with DMEM (Gibco, Objective: To explore effect of 5-AZn-2 '-deoxycytidine on proliferation of human lung adenocarcinoma cell line A549 in vitro. Methods: Superoxide dismutase (SOD) activity was measured by hydroxylamine colorimetric method. Inhibition effect of 5-AZn-2' deoxycytidylic acid at different concentration and different time on growth of A549 cell was determined by MTT assay. Methylene dioxyamphetamine (MDA) was measured by thiobarbituric acid colorimetric method. Effect of 5-AZn-2' deoxycytidylic acid on apoptosis of A549 cell was determined by Hoechst 33258 dyeing detection. Results: 5-AZn-2' deoxycytidylic acid had significant inhibition effect on proliferation of A549 cells in vitro, and the inhibition was notably dependent on time and dosage during 48-72 h; SOD level was significantly lower than those of control group (P<0.05, P<0.01), MDA level was significantly higher than those in the control group (P<0.05, P<0.01). A549 cells began to be in apoptosis after using 5-AZn-2 ' deoxycytidylic acid. Conclusions: 5-AZn-2' deoxycytidylic acid has significant inhibition effect on growth of A549 cell, and can lead the change of lipid peroxidation. It indicates that the mechanism has relationship with A549 cell cycle tissue and induction factor of apoptosis.
Carlsbad, CA, USA) containing 10% fetal bovine serum (Sijiqing, Zhejiang Tianhang Biological Technology Co., Ltd., China) in an incubator at 37 曟 , 5% CO 2 with saturated humidity and then digested with 0.25% trypsin for passage.
Drugs and reagents
DAC (Shanghai Hualian Pharmaceutical Co., Ltd., Shanghai, China) was prepared into 1 mol/L solution with physiological saline and diluted into the required concentrations with DMEM when use. MTT solution was purchased from Huamei Bioengineering Co., Ltd., China. Hochest33258 and dimethyl sulfoxide (DMSO) were purchased from Sigma, St. Louis, MO, USA.
Methods
Cell line and cell culture
Human lung adenocarcinoma epithelial cell line A549 was cultured with RPMI-1640 culture medium containing 10% fetal bovine serum, 100 U/mL penicillin and 100 U/mL streptomycin at 37 曟 , 5%CO 2 with saturated humidity. When cells reached 80% confluence, they were digested with 0.25% trypsin for passage.
DAC preparation
100 mmol/L DAC stock solution was prepared with a small amount of DMSO by applying an ultrasonic wave. Prior to experiment, DAC was diluted to the required concentration (DMSO final concentration < 0.1%) with RPMI-1640 culture medium.
MTT assay
Human lung adenocarcinoma epithelial cell line A549 at the log phase of growth were seeded into a 96-well plate, 2 暳 10 3 cells/well. After 12 h of culture, these cells were incubated with DMSO (control group) or different concentrations (0, 0.25, 0.5, 2.5, 12.5 毺 mol/L) of DAC solution (DAC groups) at 37 曟 and 5% CO 2 under saturated humidity for 12, 24, 48 and 72 h. Five parallel wells were designated for each group. After removal of supernatant, 20 毺 L MTT solution (5 g/L) was added to each well and A549 cells were incubated at 37 曟 for 4 more hours. Supernatant was removed, then 150 毺 L DMSO was added to each well and A549 cells were oscillated for 10 min. Absorbance at 490 nm was determined through the use of ELISA reader. Each experiment was repeated three times. Cell growth curve was drawn and cell growth inhibitory rate was calculated according to the formula: Cell growth inhibitory rate (%) = (1absorbance in the DAC group/absorbance rate in the control group) 暳 100%.
Cell morphology and cell apoptosis rate
Cell apoptosis in each group was detected using Hoechst 33258 staining. A549 cells (2 暳 10 4 /well) were seeded in each well in which a piece of sterile coverslip was pre-placed and five parallel wells were used for each group. When adhering to culture plate, A549 cells were treated with different concentrations of DAC (0, 0.25, 0.5, 2.5, 12.5 毺 mol/L) or DMSO for 24, 48, 72 and 96 h. Culture medium was removed, then A549 cells were collected, washed and evenly smeared. After natural drying, the cells were treated with 0.05 mg/L Hoechst33258 and 0.1 mg/L calcium-and magnesiumfree thiomersal for 40 min. After mounting, the cells were observed under the fluorescence microscope, photographed and counted.
Detection of superoxide dismutase (SOD) and malondialdehyde (MDA) activities in A549 cells
In strict accordance with the instructions of reagent kits provided by Nanjing Juli Biomedical Engineering Institute (Nanjing, China), SOD activity was measured by hydroxylamine chromatometry and MDA activity by thiobarbituric acid-reactive-substances assay.
Statistical analysis
All data were expressed as mean 暲 SD and statistically processed with SPSS16.0 software (SPSS, Chicago, IL, USA). t test was used. A level of P<0.05 was considered statistically significant. 
Results
Effects of DAC on A549 cell proliferation
Effects of DAC on SOD and MDA activities in A549 cells
The SOD activity in the DAC (0.5, 2.5 and 12.5 毺 mol/L) groups was significantly, dose-dependently lower compared with the control group (P<0.05, P<0.01). The MDA activity in the DAC (0.5, 2.5 and 12.5 毺 mol/L) groups was significantly, dose-dependently higher compared with the control group (P<0.05, P<0.01) (Table 1) . 
Effects of DAC on A549 cell apoptosis rate and morphology
Five visual fields were randomly selected under high-fold magnification for counting total cells and apoptotic cells. Cell apoptosis rate was calculated according to the formula: cell apoptosis rate = number of apoptotic cells/total cell number 暳 100%. Cell apoptosis rate reached its peak in the DAC (0.5, 2.5, 12.5 毺 mol/L) groups at 48 and 72 h, which was significantly higher compared to the control group (P<0.05, P<0.01) ( Table 2 ). Hoechst33258 fluorescent staining showed that after 72 h of DAC treatment, cell fluorescent staining was light and even and no apoptotic cells were observed in the control group ( 
Discussion
The development and apoptosis of tumor cells result from coaction of many proteins and proteases in the human body. Cell apoptosis is the process of programmed cell death and controlled by genes [9, 10] . This process can help protect the environment in the human body because only programmed cell growing and apoptosis can balance and stabilize the environment in the human body. This principle is used by gene therapy, a treatment method of tumor, which uses drugs (such as 5-fluorouracil, cisplatin, mitomycin, DAC and Chinese herbal medicine) that can lead to programmed death of tumor cells. Abnormal cell apoptosis can give rise to tumor formation, abnormal immunological function and changes in cell biological characteristics [11] [12] [13] [14] . Results from this study showed that DAC inhibited the proliferation of A549 cells as confirmed by MTT assay; that is to say, DAC promoted the death of tumor cells and inhibited the proliferation of tumor cells.
The effects of DAC on A549 cells are greatly different at different doses and for different periods of time, so much care needs to be taken over the dose and periods of time [15, 16] . In this study, we also observed the morphology of DAC-treated A549 cells and found that the cancer cells turned from spreading status before DAC treatment to round appearance with apoptotic characteristics including cell shrinkage, nuclear chromatin concentration, nuclear fragmentation, budding and apoptotic body formation after DAC treatment. Cell apoptosis rate reached its peak after DAC (0.5, 2.5 and 12.5 毺 mol/L) treatment for 48 and 72 h, respectively.
Under normal circumstance, the generation and removal of reactive oxygen species are dynamically balanced. When the organisms are stimulated by some abnormal physiochemical factors, a large amount of reactive oxygen species will be produced, which destroy the balance of oxidation-reduction, and excessive reactive oxygen species will cause lipid peroxidation [17] [18] [19] . MDA is the end-product of lipid peroxidation. Increased MDA activity indicates the unbalance between DAC oxidation and anti-oxidation [20, 21] . Results from this study showed that MDA activity increased dose-dependently in DAC-treated A549 cells. SOD activity decreased in DAC-treated A549 cells possibly because DAC inactivated SOD by binding SOD dynamic sites, especially sulfhydryl-containing protein groups. This inevitably decreases the ability of organism to remove free radicals and increases intracellular oxidation, thereby causing oxidative damage [22] [23] [24] [25] . Results from this study suggest that DAC anti-cancer drugs are effective in the treatment of lung cancer by causing lung cancer cell apoptosis and changes in lipid peroxidation, providing experimental evidence for their clinical application. The underlying mechanism needs further investigation.
